BioCentury | Dec 22, 2020
Targets & Mechanisms

Tissue-targeting autoantibodies as a driver of long COVID

...alpha and beta receptor 1IL-18 – Interleukin-18 Sandi Wong Yale School of Medicine covid-19 covid19 cov19sci chs2020 bee2021 cov19sci...
BioCentury | Nov 21, 2020
Politics, Policy & Law

Fate of Trump’s 11th hour drug price rules uncertain

...cited a  study by researchers at the Yale School of Medicine...
BioCentury | Nov 10, 2020
Politics, Policy & Law

Biden sticks with science, public health expertise for COVID-19 advisory board

...research focuses on healthcare equity.Nunez-Smith is founding director of the Equity Research and Innovation Center (ERIC) at Yale School of Medicine...
...that had strong political backing but lacked scientific merit. Danielle Golovin U.S. Food and Drug Administration (FDA) Yale University Yale School of Medicine COVID-19 cov19pol chs2020 cov19pol...
BioCentury | Nov 6, 2020
Targets & Mechanisms

Data Byte: newly identified host factors that regulate ACE2 expression

...entry —some by regulating ACE2 expression. Yale School of Medicine...
...York University Icahn School of Medicine at Mount Sinai Yale School of Medicine Broad...
BioCentury | Sep 11, 2020
Product Development

Yale’s Akiko Iwasaki shows SARS-CoV-2 invades neurons

...did not respond to BioCentury in time for comment.TARGETSACE2 – Angiotensin-converting enzyme 2 Sandi Wong AZD1222 (ChAdOx1 nCoV-19) Yale School of Medicine AstraZeneca...
BioCentury | Jun 23, 2020
Politics, Policy & Law

Scientists warn Trump immigration ‘pause’ will harm biopharma innovation

...that’s happened to US science and innovation,” tweeted Akiko Iwasaki, professor of immunology at the Yale School of Medicine...
BioCentury | May 28, 2020
Distillery Therapeutics

Reducing kidney damage in lupus by targeting HIF1A

...published online April 8, 2020 doi:10.1126/scitranslmed.aay1620 CONTACT: Joseph Craft, Yale School of Medicine, New Haven, Conn. email: joseph.craft@yale.edu Claire Quang Yale School of Medicine Hypoxia-inducible...
BioCentury | May 1, 2020
Distillery Therapeutics

Disrupting hypoxia signaling to treat a muscular dystrophy

...School, Boston, Mass. email: kunkel@enders.tch.harvard.edu CONTACT: Louis M. Kunkel, Yale School of Medicine, New Haven, Conn. email: angela.lek@yale.edu Claire Quang Yale School of Medicine Harvard...
BioCentury | Apr 3, 2020
Distillery Therapeutics

Preventing HPV infection with a capsid protein-based peptide

...published online March 2, 2020 doi:10.1073/pnas.1917748117 CONTACT: Daniel DiMaio, Yale School of Medicine, New Haven, Conn. email: daniel.dimaio@yale.edu Claire Quang Yale School of Medicine...
BioCentury | Feb 28, 2020
Distillery Therapeutics

Epigenetic enzyme Tet3 as target in liver fibrosis

...Medicine, New Haven, Conn. email: leeda@ymail.com CONTACT: Yingqun Huang, same affiliation as above email: yingqun.huang@yale.edu Claire Quang Yale School of Medicine...
Items per page:
1 - 10 of 154
BioCentury | Dec 22, 2020
Targets & Mechanisms

Tissue-targeting autoantibodies as a driver of long COVID

...alpha and beta receptor 1IL-18 – Interleukin-18 Sandi Wong Yale School of Medicine covid-19 covid19 cov19sci chs2020 bee2021 cov19sci...
BioCentury | Nov 21, 2020
Politics, Policy & Law

Fate of Trump’s 11th hour drug price rules uncertain

...cited a  study by researchers at the Yale School of Medicine...
BioCentury | Nov 10, 2020
Politics, Policy & Law

Biden sticks with science, public health expertise for COVID-19 advisory board

...research focuses on healthcare equity.Nunez-Smith is founding director of the Equity Research and Innovation Center (ERIC) at Yale School of Medicine...
...that had strong political backing but lacked scientific merit. Danielle Golovin U.S. Food and Drug Administration (FDA) Yale University Yale School of Medicine COVID-19 cov19pol chs2020 cov19pol...
BioCentury | Nov 6, 2020
Targets & Mechanisms

Data Byte: newly identified host factors that regulate ACE2 expression

...entry —some by regulating ACE2 expression. Yale School of Medicine...
...York University Icahn School of Medicine at Mount Sinai Yale School of Medicine Broad...
BioCentury | Sep 11, 2020
Product Development

Yale’s Akiko Iwasaki shows SARS-CoV-2 invades neurons

...did not respond to BioCentury in time for comment.TARGETSACE2 – Angiotensin-converting enzyme 2 Sandi Wong AZD1222 (ChAdOx1 nCoV-19) Yale School of Medicine AstraZeneca...
BioCentury | Jun 23, 2020
Politics, Policy & Law

Scientists warn Trump immigration ‘pause’ will harm biopharma innovation

...that’s happened to US science and innovation,” tweeted Akiko Iwasaki, professor of immunology at the Yale School of Medicine...
BioCentury | May 28, 2020
Distillery Therapeutics

Reducing kidney damage in lupus by targeting HIF1A

...published online April 8, 2020 doi:10.1126/scitranslmed.aay1620 CONTACT: Joseph Craft, Yale School of Medicine, New Haven, Conn. email: joseph.craft@yale.edu Claire Quang Yale School of Medicine Hypoxia-inducible...
BioCentury | May 1, 2020
Distillery Therapeutics

Disrupting hypoxia signaling to treat a muscular dystrophy

...School, Boston, Mass. email: kunkel@enders.tch.harvard.edu CONTACT: Louis M. Kunkel, Yale School of Medicine, New Haven, Conn. email: angela.lek@yale.edu Claire Quang Yale School of Medicine Harvard...
BioCentury | Apr 3, 2020
Distillery Therapeutics

Preventing HPV infection with a capsid protein-based peptide

...published online March 2, 2020 doi:10.1073/pnas.1917748117 CONTACT: Daniel DiMaio, Yale School of Medicine, New Haven, Conn. email: daniel.dimaio@yale.edu Claire Quang Yale School of Medicine...
BioCentury | Feb 28, 2020
Distillery Therapeutics

Epigenetic enzyme Tet3 as target in liver fibrosis

...Medicine, New Haven, Conn. email: leeda@ymail.com CONTACT: Yingqun Huang, same affiliation as above email: yingqun.huang@yale.edu Claire Quang Yale School of Medicine...
Items per page:
1 - 10 of 154